Assignee
FUNDAMENTAL PHARMA GMBH
DE·0 granted patents·3 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
3 records- 0154US2025339402A1Effective means to modulate nmda receptor-mediated toxicityFUNDAMENTAL PHARMA GMBH·Filed 2023·Application pending·0 cites
- 0242US2023340060A1Novel means to predict and manipulate nmda receptor-mediated toxicityFUNDAMENTAL PHARMA GMBH·Filed 2021·Application pending·0 cites
- 0332US2021347846A1Novel means to modulate nmda receptor-mediated toxicityFUNDAMENTAL PHARMA GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FUNDAMENTAL PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →